
Jo Anne Zujewski, MD, head, breast cancer therapeutics, cancer therapy evaluation program, National Cancer Institute, discusses the FDA approval process for oncology drugs.

Your AI-Trained Oncology Knowledge Connection!


Published: October 1st 2013 | Updated: